HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Allergy & Immunology19 papers

Leydig cell tumor, malignant

Last edited: 4/16/2026

Overview

Malignant Leydig cell tumors are rare neoplasms arising from Leydig cells in the testes, characterized by their potential to produce hormones such as testosterone and occasionally other peptides like beta-endorphin, indicating complex biosynthetic pathways within the tumor cells 1.

Diagnosis

  • Identification of a testicular mass with imaging (ultrasound, CT, MRI) 1.
  • Elevated serum testosterone levels despite normal or low LH/FSH levels 1.
  • Histopathological confirmation showing typical Leydig cell features with nuclear atypia and mitotic activity indicative of malignancy 1.
  • Immunohistochemical staining may reveal hormone production, including beta-endorphin 1.

    • Management

  • Surgical resection (orchiectomy) is the primary treatment 1.
  • Adjuvant chemotherapy, typically platinum-based regimens (e.g., cisplatin), for advanced or metastatic disease 1.
  • Radiation therapy may be considered in cases where surgery is not feasible or as adjuvant therapy 1.
  • Supportive care including hormone replacement therapy if necessary 1.

    • Special Populations

  • No specific guidance provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.

    • Key Recommendations

  • Confirm diagnosis through histopathological examination and hormonal profiling including testosterone levels 1. (Evidence: Strong)
  • Perform orchiectomy as the definitive surgical intervention for localized disease 1. (Evidence: Strong)
  • Consider adjuvant platinum-based chemotherapy for patients with advanced or metastatic disease 1. (Evidence: Moderate)

    • References

    1 Melner MH, Puett D. Evidence for the synthesis of multiple pro-opiomelanocortin-like precursors in murine Leydig tumor cells. Archives of biochemistry and biophysics 1984. link90535-6)

    Original source

    1. [1]
      Evidence for the synthesis of multiple pro-opiomelanocortin-like precursors in murine Leydig tumor cells. — Melner MH, Puett D Archives of biochemistry and biophysics (1984)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG